DEA Cracks Down On Synthetic Cannabinoids, Classifies These Six As Schedule I Drugs

Zinger Key Points
  • The DEA issued a temporary order under the Controlled Substances Act scheduling six synthetic cannabinoids in Schedule I.
  • The six cannabinoids are synthesized in laboratories that mimic the biological effects of delta-9-tetrahydrocannabinol (THC).

The Drug Enforcement Administration (DEA) has issued a temporary order under the Controlled Substances Act, scheduling six synthetic cannabinoids in Schedule I.

"This action is based on a finding by the Administrator that the placement of these six substances in schedule I is necessary to avoid imminent hazard to the public safety," the DEA announced on Tuesday.

The temporary order took effect immediately and will stay in place until December 12, 2025.

Green Market Report's Debra Borchardt highlighted these items can be purchased at gas stations, convenience stores, and smoke shops, where they are known as herbal incense and marketed as a legal alternative to cannabis.

See also: DEA Weighs In On Legality Of THCA, Delta-8 And Other Minor Cannabinoids

The six cannabinoids include:

  • Methyl 3,3-dimethyl-2-(1-(pent-4- en-1-yl)-1H-indazole-3- carboxamido)butanoate (Other name: MDMB–4en–PINACA)
  • Methyl 2-[[1-(4-fluorobutyl)indole- 3-carbonyl]amino]-3,3-dimethyl- butanoate (Other names: 4F–MDMB– BUTICA; 4F–MDMB–BICA)
  • N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H- indazole-3-carboxamide (Other name: ADB–4en–PINACA)
  • 5-Pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one (Other name: CUMYL–PEGACLONE; SGT– 151)
  • Ethyl 2-[[1-(5-fluoropentyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate (Other names: 5F–EDMB–PICA; 5F– EDMB–2201
  • Methyl 2-(1-(4-fluorobenzyl)-1H- indole-3-carboxamido)-3-methyl butanoate (Other name: MMB–FUBICA)

The document stipulates that "synthetic cannabinoids (SCs) are substances synthesized in laboratories that mimic the biological effects of delta-9-tetrahydrocannabinol (THC, schedule I), the main psychoactive ingredient in marijuana (Schedule I).”

There have been numerous fatalities documented related to MDMB- 4en-PINACA, 4F-MDMB-BUTICA, and CUMYL-PEGACLONE, according to the notice.

"Based on the pharmacological similarities between MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL- PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA and other schedule I SCs, these six SCs are likely to produce signs of addiction and withdrawal," the DEA said of products that are usually exported by China as powdered substances in large quantities and are illicitly brought into the United States.

Now read: Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisGovernmentNewsRegulationsDEASynthetic cannabinoids
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...